Amendment S-3112 to HF 555

Filed March 30, 2023 in the Senate by

What it changes

1. Page 1, by striking lines 11 and
3. Page 1, line 34, after “drug” by inserting “, biological product, or device”
4. Page 1, line 35, before “with” by inserting “or device”
5. Page 2, line 1, after “drug” by inserting “, biological product, or device”
6. Page 4, by striking lines 21 through
8. Page 5, by striking lines 12 through
10. Page 10, line 2, after “board.” by inserting “The board shall not develop or approve a statewide protocol permitting a pharmacist to order and administer any drug intended to induce an abortion as defined in section 146.l.”
11. Page 12, after line 10 by inserting: “Sec. ___. Section 514F.7, subsection 4, paragraph a, Code 2023, is amended to read as follows: a. Prevent a health carrier, health benefit plan, or utilization review organization from requiring a covered person to try a prescription drug with the same generic name and demonstrated bioavailability or a biological product that is an interchangeable biological product pursuant to section 155A.32 as defined in section 155A.3 prior to providing coverage for the equivalent branded prescription drug.”
12. Page 12, line 11, after “155A.6B,” by inserting “155A.11,”
13. By renumbering, redesignating, and correcting internal references as necessary.

Official amendment (PDF) · In the Bill Book